D.A. Davidson & Co. Astrazeneca PLC Transaction History
D.A. Davidson & Co.
- $13.8 Billion
- Q2 2025
A detailed history of D.A. Davidson & Co. transactions in Astrazeneca PLC stock. As of the latest transaction made, D.A. Davidson & Co. holds 37,163 shares of AZN stock, worth $3.12 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
37,163
Previous 36,054
3.08%
Holding current value
$3.12 Million
Previous $2.65 Million
2.0%
% of portfolio
0.02%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
498MCall Options Held
7.11MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...